In 2023, the United States had the highest recorded mortality for trachea, bronchus, or lung malignant neoplasms among males, followed by Japan and Germany. The latest data indicates a marginal decline in the United States, while Japan showed a slight increase. Other major countries like Germany and the UK also experienced declines. Growth was noted in Brazil, South Korea, and a few other nations. Despite differing trends, general 5-year growth patterns demonstrate a continued decline in most European nations and Canada, suggesting progress in public health initiatives and smoking cessation efforts.
Looking forward, potential global trends might include increased awareness, preventive measures such as anti-smoking campaigns, and advances in early detection and treatment technologies, particularly in high-burden nations. We should anticipate continual improvements in the overall mortality rates; however, the varying speeds and efficiencies of health policy implementation across countries will influence these outcomes.
Top countries in Trachea, Bronchus or Lung Malignant Neoplasms Mortality by Country
| # | 10 Countries | Units (Male Deaths) | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 United States | 67,450 | 2023 | -2.58% | -2.43% | View data |
| 2 | 2 Japan | 53,720 | 2023 | +0.31% | +0.5% | View data |
| 3 | 3 Germany | 26,580 | 2023 | -1.34% | -1.3% | View data |
| 4 | 4 Brazil | 16,930 | 2023 | +1.34% | +0.67% | View data |
| 5 | 5 United Kingdom | 16,810 | 2023 | -2.16% | -1.99% | View data |
| 6 | 6 Spain | 16,360 | 2023 | -0.92% | -0.98% | View data |
| 7 | 7 South Korea | 14,560 | 2023 | +1.62% | +1.99% | View data |
| 8 | 8 Poland | 13,280 | 2023 | -2.69% | -3.21% | View data |
| 9 | 9 Canada | 10,430 | 2023 | 0% | -0.1% | View data |
| 10 | 10 Romania | 7,430 | 2023 | -0.13% | -0.6% | View data |
